Tracer library / [177Lu]Lu-DOTA-PEG-CPNs
[177Lu]Lu-DOTA-PEG-CPNs
Also written as [177Lu]Lu-DOTA-PEG-CPNs
- Radionuclide
- Lu-177
- Modality
- —
- Production route
- —
- Stage
- Preclinical
- Syntheses indexed
- 0
What it is
- Compound class
- DOTA-conjugated PEGylated conjugated polymer nanoparticle (CPN)
- Target / mechanism
- —
- Clinical application
- Breast cancer targeted radionuclide therapy PMID 38050716
- Theranostic pair
- —
Published syntheses
No synthesis has been parsed for this agent yet.
Need this precursor?We can point you to suppliers for [177Lu]Lu-DOTA-PEG-CPNs, or handle the enquiry for you.
Get in touchNotes
Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 37939492, 38050716. Stage set/updated at stage 39 from PMID 38050716: 'A Proof-of-Concept Study on the Theranostic Potential of 177 Lu-labeled Biocompatible Covalent Polymer Nanoparticles for Cancer Targeted Radionuclide Therapy.'.